Our findings provide the first evidence that ANO6 (TMEM16F) inhibits GIST growth and induces ferroptosis by regulating SLC7A11 and SLC3A2C expression, thereby providing a therapeutic basis for GIST treatment. This evidence concerns the gene SLC7A11 and gastrointestinal stromal tumor.